40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
237.14%
Net income growth 1.25-1.5x CNQ's 194.59%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
41.11%
D&A growth well above CNQ's 5.65%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
354.84%
Some yoy growth while CNQ is negative at -1544.68%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-136.96%
Both cut yoy SBC, with CNQ at -111.29%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-62.71%
Negative yoy working capital usage while CNQ is 122.64%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-132.76%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.71%
Negative yoy usage while CNQ is 122.64%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
51.02%
Lower 'other non-cash' growth vs. CNQ's 113.59%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
71.27%
Operating cash flow growth below 50% of CNQ's 187.25%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-1.90%
Negative yoy CapEx while CNQ is 0.72%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-120.27%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-155.56%
Both yoy lines negative, with CNQ at -15.03%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-30.76%
Both yoy lines negative, with CNQ at -333.82%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2505.00%
Both yoy lines negative, with CNQ at -9.62%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-59.25%
Both yoy lines negative, with CNQ at -62.24%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.